The wires and cables industry has witnessed revenue CAGR of around 13 per cent between FY19 to FY24 powered by shift in market share from unorganised to the organised players. | Photo Credit ...
This acquisition, effective from March 1, values Kesoram at Rs 7,600 crore. UltraTech will also enter the wires and cables market with a Rs 1,800 crore investment. Kesoram's cement units will ...
The Aditya Birla Group's flagship company also said it will enter wires and cables segment with Rs 1,800-crore capex. As per scheme of arrangement, one share of UltraTech Cement will be issued for ...
Learn more › Speaker wire is the unsung hero of any good two-channel audio setup, and even home theater components. Even the most affordable interconnects can have your speakers pumping in no time.
Feb 25 (Reuters) - UltraTech Cement (ULTC.NS), opens new tab, India's top cement maker by capacity, will spend 18 billion rupees ($206 million) to start up a wires and cables business, deepening ...
Aditya Birla Group foray into the cable and wires (C&W) business through Ultratech, with an investment outlay of Rs 1,800 crore, is weighing on the share prices of the leading players in the industry.
The cable and wire stocks are in focus this morning. Stocks like Havells, KEI, Polycab and RR Kabel plunged as much as 13 percent intra-day on the news of entry of Ultratech in this segment.
UltraTech Cement, India’s largest cement manufacturer, announced its foray into the wires and cables business with an initial capital expenditure of ₹1,800 crore over two years. The company ...
Share this Share on Facebook Share on Twitter Share on LinkeIn New insight from the boutique debt advisory and investments firm, Excellion Capital, reveals how real estate developers can produce ...
Deshaun Watson and girlfriend Jilly Anais announce their engagement amidst his uncertain NFL career and injury setbacks. Watson, recently plagued by injuries, faces a challenging future with the ...
Roux-en-Y gastric bypass (RYGB) led to greater excess body mass index (BMI) loss than sleeve gastrectomy in patients with severe obesity over 10 years, with the latter procedure being associated ...
ESCONDIDO, Calif.--(BUSINESS WIRE)--BTB Therapeutics, Inc., a clinical-stage drug development company developing a non-opioid pain medicine ENDOPIN, today announced the election of David R.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results